Association of ABO blood group with bleeding severity in patients with bleeding of unknown cause
The DOI matches its Crossref record.
Abstract
Blood group O has been associated with an increased bleeding tendency due to lower von Willebrand factor (VWF) and factor VIII (FVIII) levels. We explored whether blood group O is independently associated with bleeding severity in patients with mild-to-moderate bleeding of unknown cause (BUC) in the Vienna Bleeding Biobank cohort. Bleeding severity was recorded with the Vicenza bleeding score (BS). Blood group O was overrepresented in 422 patients with BUC compared with its presence in 23 145 healthy blood donors (47.2% vs 37.6%; odds ratio, 1.48; 95% confidence interval [CI], 1.22-1.79). The BS and the number of bleeding symptoms were significantly higher in patients with blood group O than in patients with non-O after adjustment for VWF and FVIII levels and sex (least-square [LS] means of BSs: 6.2; 95% CI, 5.8-6.6 vs 5.3; 4.9-5.7; and of number of symptoms: LS, 3.5; 95% CI, 3.2-3.7 vs 3.0; 2.8-3.2, respectively). Oral mucosal bleeding was more frequent in those with blood group O than in those with other blood types (group non-O; 26.1% vs 14.3%), independent of sex and VWF and FVIII levels, whereas other bleeding symptoms did not differ. Patients with blood group O had increased clot density in comparison with those with blood group non-O, as determined by rotational thromboelastometry and turbidimetric measurement of plasma clot formation. There were no differences in thrombin generation, clot lysis, or platelet function. Our data indicate that blood group O is a risk factor for increased bleeding and bleeding severity in patients with BUC, independent of VWF and FVIII levels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Individuals with blood group O have 20%–30% lower von Willebrand Factor (vWF) and factor VIII (FVIII) levels compared with individuals with non-O blood groups”
From ABO blood group antigens and differential glycan expression: Perspective on the evolution of common human enzyme deficiencies (2023) · cites this paper as Mehic et al., 2020
In the citing paper
“ABO(H) antigens are also expressed on platelet glycoproteins and may also contribute to the differences in bleeding and thrombotic tendency in individuals of different blood groups”
From ABO blood group antigens and differential glycan expression: Perspective on the evolution of common human enzyme deficiencies (2023) · cites this paper as Mehic et al., 2020
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 36
- Desch, 2018, Regulation of plasma von Willebrand factor, F1000 Res, 7, 96, 10.12688/f1000research.13056.1 · DOI
- Gill, 1987, The effect of ABO blood group on the diagnosis of von Willebrand disease, Blood, 69, 1691, 10.1182/blood.V69.6.1691.1691 · DOI · Paper page
- Flood, 2016, Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States, Blood, 127, 2481, 10.1182/blood-2015-10-673681 · doi:10.1182/blood-2015-10-673681
- Franchini, 2014, ABO blood group and von Willebrand factor: biological implications, Clin Chem Lab Med, 52, 1273, 10.1515/cclm-2014-0564 · DOI
- Dick, 1963, Interrelations of thrombo-embolic disease and blood group distribution, Thromb Diath Haemorrh, 143, 472
- Morelli, 2005, ABO blood group genotypes and the risk of venous thrombosis: effect of factor V Leiden, J Thromb Haemost, 3, 183, 10.1111/j.1538-7836.2004.01071.x · DOI
- Dentali, 2013, Relationship between ABO blood group and hemorrhage: a systematic literature review and meta-analysis, Semin Thromb Hemost, 39, 72, 10.1055/s-0032-1329550 · doi:10.1055/s-0032-1329550
- Evans, 1968, Influence of the ABO blood groups and secretor status on bleeding and on perforation of duodenal ulcer, Gut, 9, 319, 10.1136/gut.9.3.319 · DOI
- Viskum, 1972, Long-term survival of patients with gastrointestinal haemorrhage with special reference to the ABO blood groups, Scand J Gastroenterol, 7, 55, 10.3109/00365527209180739 · doi:10.3109/00365527209180739
- Merikas, 1966, Distribution of ABO blood groups in patients with ulcer disease. Its relationship to gastroduodenal bleeding, Am J Dig Dis, 11, 790, 10.1007/BF02233839 · doi:10.1007/bf02233839
- Lam, 1976, Duodenal ulcers: early and late onset, Gut, 17, 169, 10.1136/gut.17.3.169 · doi:10.1136/gut.17.3.169
- Berg, 1969, Influence of age and ABO blood groups in the precipitation of bleeding peptic ulcers, Gut, 10, 1029, 10.1136/gut.10.12.1029 · doi:10.1136/gut.10.12.1029
- Clark, 2008, The GOAL study: a prospective examination of the impact of factor V Leiden and ABO(H) blood groups on haemorrhagic and thrombotic pregnancy outcomes, Br J Haematol, 140, 236, 10.1111/j.1365-2141.2007.06902.x · DOI
- Chauleur, 2008, Some hemostasis variables at the end of the population distributions are risk factors for severe postpartum hemorrhages, J Thromb Haemost, 6, 2067, 10.1111/j.1538-7836.2008.03168.x · DOI
- Lethagen, 2008, Distribution of von Willebrand factor levels in young women with and without bleeding symptoms: influence of ABO blood group and promoter haplotypes, Thromb Haemost, 99, 1013, 10.1160/TH07-06-0419 · doi:10.1160/th07-06-0419
- Garcia, 2006, The relationship between ABO blood group and the risk of bleeding during vitamin K antagonist treatment, J Thromb Haemost, 4, 1418, 10.1111/j.1538-7836.2006.01962.x · doi:10.1111/j.1538-7836.2006.01962.x
- Quiroga, 1997, Skin and mucous membrane hemorrhages: clinical assessment, study sequence and relative frequency of hereditary diseases of the hemostasis in a Chilean population [in Spanish], Rev Med Chil, 125, 409
- Gebhart, 2018, High proportion of patients with bleeding of unknown cause in persons with a mild-to-moderate bleeding tendency: Results from the Vienna Bleeding Biobank (VIBB), Haemophilia, 24, 405, 10.1111/hae.13422 · doi:10.1111/hae.13422
- Quiroga, 2007, High prevalence of bleeders of unknown cause among patients with inherited mucocutaneous bleeding. A prospective study of 280 patients and 299 controls, Haematologica, 92, 357, 10.3324/haematol.10816 · doi:10.3324/haematol.10816
- Mezzano, 2019, Diagnostic challenges of inherited mild bleeding disorders: a bait for poorly explored clinical and basic research, J Thromb Haemost, 17, 257, 10.1111/jth.14363 · doi:10.1111/jth.14363
- Rodeghiero, 2005, The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study, J Thromb Haemost, 3, 2619, 10.1111/j.1538-7836.2005.01663.x · doi:10.1111/j.1538-7836.2005.01663.x
- Gebhart, 2020, The discriminatory power of bleeding assessment tools in adult patients with a mild to moderate bleeding tendency, Eur J Intern Med, 78, 34, 10.1016/j.ejim.2020.04.023 · doi:10.1016/j.ejim.2020.04.023
- Haslacher, 2018, Usage Data and Scientific Impact of the Prospectively Established Fluid Bioresources at the Hospital-Based MedUni Wien Biobank, Biopreserv Biobank, 16, 477, 10.1089/bio.2018.0032 · DOI
- Spiezia, 2018, Association between ABO blood group and bleeding phenotype in patients with mild rare bleeding disorders, Haemophilia, 24, e428, 10.1111/hae.13615 · doi:10.1111/hae.13615
- Antón, 2010, Study of 18 functional hemostatic polymorphisms in mucocutaneous bleeding disorders, Ann Hematol, 89, 1147, 10.1007/s00277-010-1000-7 · doi:10.1007/s00277-010-1000-7
- Weisel, 2019, Red blood cells: the forgotten player in hemostasis and thrombosis, J Thromb Haemost, 17, 271, 10.1111/jth.14360 · DOI · Paper page
- Santoso, 1991, Blood group A and B determinants are expressed on platelet glycoproteins IIa, IIIa, and Ib, Thromb Haemost, 65, 196, 10.1055/s-0038-1647483 · doi:10.1055/s-0038-1647483
- Hou, 1996, Blood group A antigen expression in platelets is prominently associated with glycoprotein Ib and IIb. Evidence for an A1/A2 difference, Transfus Med, 6, 51, 10.1046/j.1365-3148.1996.d01-52.x · doi:10.1046/j.1365-3148.1996.d01-52.x
- Kremers, 2015, Thrombin generating capacity and phenotypic association in ABO blood groups, PLoS One, 10, e0141491, 10.1371/journal.pone.0141491 · DOI
- Choi, 2015, Influence of ABO type on global coagulation assay results: effect of coagulation factor VIII, Clin Chem Lab Med, 53, 1425, 10.1515/cclm-2014-0909 · doi:10.1515/cclm-2014-0909
- Byrnes, 2017, Red blood cells in thrombosis, Blood, 130, 1795, 10.1182/blood-2017-03-745349 · DOI · Paper page
- Weisel, 1992, Computer modeling of fibrin polymerization kinetics correlated with electron microscope and turbidity observations: clot structure and assembly are kinetically controlled, Biophys J, 63, 111, 10.1016/S0006-3495(92)81594-1 · DOI · Paper page
- Weisel, 2013, Mechanisms of fibrin polymerization and clinical implications, Blood, 121, 1712, 10.1182/blood-2012-09-306639 · DOI · Paper page
- Kovacevic, 2020, The aptamer BT200 effectively inhibits von Willebrand factor (VWF) dependent platelet function after stimulated VWF release by desmopressin or endotoxin, Sci Rep, 10, 11180, 10.1038/s41598-020-68125-9 · doi:10.1038/s41598-020-68125-9
- Pujol-Moix, 2019, Influence of ABO Locus on PFA-100 Collagen-ADP Closure Time Is Not Totally Dependent on the Von Willebrand Factor. Results of a GWAS on GAIT-2 Project Phenotypes, Int J Mol Sci, 20, 3221, 10.3390/ijms20133221 · DOI
- Dunne, 2019, Blood group alters platelet binding kinetics to von Willebrand factor and consequently platelet function, Blood, 133, 1371, 10.1182/blood-2018-06-855528 · DOI
Cited by
Jajosky, R. P., Wu, S.-C., Zheng, L., Jajosky, A. N., Jajosky, P. G., Josephson, C. D., Hollenhorst, M. A., Sackstein, R., Cummings, R. D., Arthur, C. M., et al. (2023) · iScience · doi:10.1016/j.isci.2022.105798 · Cited by 110
Metadata
- Authors
- Mehic, D., Hofer, S., Jungbauer, C., Kaider, A., Haslacher, H., Eigenbauer, E., Rejtő, J., Schwartz, D., Jilma, B., Ay, C., Pabinger, I., & Gebhart, J.
- Affiliations
- Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria;
- Austrian Red Cross, Blood Service for Vienna, Lower Austria and Burgenland, Austria; and
- Center for Medical Statistics, Informatics and Intelligent Systems,
- Department of Laboratory Medicine,
- IT-Systems and Communications,
- Department of Blood Group Serology and Transfusion Medicine, and
- Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
- Venue
- Blood Advances
- Publisher
- American Society of Hematology
- Published
- 2020-10-23
- Volume
- 4
- Issue
- 20
- Pages
- 5157-5164
- ISSN
- 2473-9529
- 2473-9537
- Cited by
- 56
- References
- 0
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Association of ABO blood group with bleeding severity in patients with bleeding of unknown cause. https://app.cochat.ai/papers/10.1182/bloodadvances.2020002452
- The paper
- Mehic, D., Hofer, S., Jungbauer, C., Kaider, A., Haslacher, H., Eigenbauer, E., Rejtő, J., Schwartz, D., Jilma, B., Ay, C., Pabinger, I., & Gebhart, J. (2020). Association of ABO blood group with bleeding severity in patients with bleeding of unknown cause. Blood Advances. https://doi.org/10.1182/bloodadvances.2020002452
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.